Advanced Renal Cell Carcinoma
Showing 9951 - 9975 of >10,000
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Paclitaxel plus 5-fluorouracil, Cisplatin plus 5-fluorouracil, Radiation
Completed
- Esophageal Squamous Cell Carcinoma
- Paclitaxel plus 5-fluorouracil
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Cancer Center
Oct 17, 2018
Cervical Cancer = FIGO IIB and or Lymph Node Metastases Trial (Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab),
Not yet recruiting
- Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
- Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
- +2 more
- (no location specified)
Aug 16, 2022
Patients With Advanced Metastatic Colorectal Cancer Trial in Wuhan (Tislelizumab plus Fruquintinib and SBRT)
Active, not recruiting
- Patients With Advanced Metastatic Colorectal Cancer
- Tislelizumab plus Fruquintinib and SBRT
-
Wuhan, Hubei, ChinaHuazhong University of Science and Technology
Aug 15, 2022
Cervical Cancer Trial in Guangzhou (Type B resection or type C resection of the anterior leaf of vesicouterine ligament during
Recruiting
- Cervical Cancer
- Type B resection or type C resection of the anterior leaf of vesicouterine ligament during the radical hysterectomy (type C)
-
Guangzhou, Guangdong, ChinaHuaiwu Lu
Jun 14, 2023
End Stage Renal Disease, Hemodialysis Trial in Clermont-Ferrand (Chlorhydric acid based acid concentrate for bicarbonate
Recruiting
- End Stage Renal Disease
- Hemodialysis
- Chlorhydric acid based acid concentrate for bicarbonate hemodialysis (medical device)
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
Feb 28, 2022
CT Perfusion Parameters for Advanced HCC Treated by Systemic
Completed
- Advanced HCC Treated by Systemic Immunotherapy
-
Nancy, FranceCHRU Nancy
Oct 13, 2022
Advanced Cancer Trial in Beijing, Tianjin (CM082 Tablet)
Completed
- Advanced Cancer
- CM082 Tablet
-
Beijing, Beijing, China
- +2 more
Jul 2, 2019
Advanced Solid Tumors Cancer Trial in Worldwide (Osimertinib, Nivolumab, Telisotuzumab vedotin)
Recruiting
- Advanced Solid Tumors Cancer
- Osimertinib
- +3 more
-
Scottsdale, Arizona
- +35 more
Jan 12, 2023
Polycystic Kidney Disease, Adult Trial in Bethlehem (Lixivaptan)
Active, not recruiting
- Polycystic Kidney Disease, Adult
-
Bethlehem, PennsylvaniaNortheast Clinical Research Center, LLC
Jun 7, 2022
Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (mDC3/8-KRAS Vaccine)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- mDC3/8-KRAS Vaccine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Apr 4, 2022
Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)
Recruiting
- Acute Myeloid Leukemia
- Fludarabine + Cyclophosphamide + TAA05 Cell Injection
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Jun 29, 2022
Advanced/Metastatic Solid Tumors Trial in Kurralta Park, Clayton (ADG206)
Not yet recruiting
- Advanced/Metastatic Solid Tumors
-
Kurralta Park, South Australia, Australia
- +1 more
Nov 9, 2022
Sarcoma Trial in Guangzhou (Fluzoparib+ Dalpiciclib)
Recruiting
- Sarcoma
- Fluzoparib+ Dalpiciclib
-
Guangzhou, Guangdong, ChinaCancer Center of Sun-Yat Sen University (CCSYSU)
Jul 11, 2023
A Nationwide Multicenter, Ambispective Real-world Study of
Recruiting
- Breast Cancer
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Sep 15, 2022
DLBCL, DLBCL Germinal Center B-Cell Type, DLBCL, Not Otherwise Specified Trial in Columbus (Molecular Nanotechnology)
Recruiting
- Diffuse Large B-Cell Lymphoma
- +3 more
- Molecular Nanotechnology
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jun 2, 2022
Adult Solid Tumor Trial (LTC004)
Not yet recruiting
- Adult Solid Tumor
- LTC004
- (no location specified)
Dec 18, 2022
Renal Colic Trial (0.9% Sodium-chloride, Placebos, Optalgin, Voltaren, Morphine)
Withdrawn
- Renal Colic
- 0.9% Sodium-chloride
- +2 more
- (no location specified)
Sep 27, 2021
Applications of MRI in Kidney Disease
Not yet recruiting
- Chronic Kidney Disease
- End-stage Kidney Disease
- No intervention but only observational
-
Minneapolis, MinnesotaUniversity of Minnesota Medical Center
Mar 28, 2022
New Fixed-dose Nivolumab Regimen With Old mg/kg Regimen in
Completed
- Metastatic Cancer
- (no location specified)
May 31, 2022
Renal Impairment in Non-alcoholic Fatty Liver Disease.
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- serum Adiponectin
- (no location specified)
Oct 23, 2021
Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded
Not yet recruiting
- Refractory Leukemia
- +4 more
- STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
- Dendritic Cell Vaccine
-
Miami, FloridaUniversity of Miami
Jan 23, 2023
Chemo, Colorectal Cancer, Intestinal Mucositis Trial (Losartan 50mg Tab)
Not yet recruiting
- Chemotherapy
- +3 more
- Losartan 50mg Tab
- (no location specified)
May 13, 2023
Carcinoma, Renal Cell Trial in Houston (Sunitinib, Temsirolimus, Sorafenib)
Terminated
- Carcinoma, Renal Cell
- Sunitinib
- +5 more
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Sep 12, 2018
Bleeding, Hemoptysis Trial in Zagreb (Tranexamic acid, Adrenaline, Placebo)
Not yet recruiting
- Bleeding
- Hemoptysis
- Tranexamic acid
- +2 more
-
Zagreb, CroatiaUniversity Hospital Centre Zagreb
Nov 20, 2023
Spanish Real World Data on Patients Treated With Durvalumab
Completed
- Small Cell Lung Cancer (SCLC)
-
Santiago De Compostela, A Coruña, Spain
- +38 more
Jun 2, 2022